Literature DB >> 3281267

Antimetastatic agents. I. Role of cellular procoagulants in the pathogenesis of fibrin deposition in cancer and the use of anticoagulants and/or antiplatelet drugs in cancer treatment.

F R Rickles1, W W Hancock, R L Edwards, L R Zacharski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3281267     DOI： 10.1055/s-2007-1002760

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN： 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  9 in total

Review 1.  Non-tissue factor procoagulants in cancer cells.

Authors:  S G Gordon; M Chelladurai
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer.

Authors:  Takashi Suzuki; Hideaki Shimada; Tatsuki Nanami; Yoko Oshima; Satoshi Yajima; Masaaki Ito; Naohiro Washizawa; Hironori Kaneko
Journal:  Surg Today       Date:  2016-05-09       Impact factor: 2.549

Review 3.  Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.

Authors:  M Shoji; W W Hancock; K Abe; C Micko; K A Casper; R M Baine; J N Wilcox; I Danave; D L Dillehay; E Matthews; J Contrino; J H Morrissey; S Gordon; T S Edgington; B Kudryk; D L Kreutzer; F R Rickles
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

4.  Prognostic significance of hyperfibrinogenemia in patients with esophageal squamous cell carcinoma.

Authors:  Takashi Suzuki; Hideaki Shimada; Tatsuki Nanami; Yoko Oshima; Satoshi Yajima; Naohiro Washizawa; Hironori Kaneko
Journal:  Int J Clin Oncol       Date:  2017-01-07       Impact factor: 3.402

Review 5.  Hemostatic alterations in cancer patients.

Authors:  F R Rickles; M Levine; R L Edwards
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

Review 6.  The role of fibrin in tumor metastasis.

Authors:  V Costantini; L R Zacharski
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

7.  Factor IXi-antithrombin (IXiAT) and thrombin-antithrombin (TAT) complexes in lung cancer patients.

Authors:  B Kemkes-Matthes; H Bleyl
Journal:  Ann Hematol       Date:  1992-01       Impact factor: 3.673

8.  Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomes.

Authors:  Bo H Chao; Lisa Lepeak; Ticiana Leal; H Ian Robins
Journal:  Thrombosis       Date:  2011-04-12

9.  Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line.

Authors:  T A Drake; W Ruf; J H Morrissey; T S Edgington
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.